Advertisement
Home »

High rate of adverse drug reactions with a novel tuberculosis retreatment regimen combining triple-doses of both isoniazid and rifampicin.

May 08, 2023

ABOUT THE EXPERTS

  • Mahamadou Bassirou Souleymane

    Damien Foundation, Niamey, Niger. Electronic address: bachirsoul@gmail.com.

    Sani Kadri

    National Hospital of Niamey, Niger.

    Alberto Piubello

    Damien Foundation, Brussels, Belgium.

    Achilleas Tsoumanis

    Institute of Tropical Medicine, Clinical Trials Unit, Antwerp, Belgium.

    Alphazazi Soumana

    Programme National de Lutte contre la Tuberculose, Coordination nationale, Niamey, Niger.

    Hamidou Issa

    University of Zinder, Faculty of Health Sciences, Zinder, Niger.

    Abdoulaziz Kabirou Amoussa

    Centre Hospitalier régional de Maradi, CAT, Maradi, Niger.

    Armand Van Deun

    Independent Consultant, Leuven, Belgium.

    Lutgarde Lynen

    Institute of Tropical Medicine, TB-HIV Unit, Antwerp, Belgium.

    Bouke Catherine de Jong

    Institute of Tropical Medicine, Unit of Mycobacteriology, Antwerp, Belgium.

    Tom Decroo

    Institute of Tropical Medicine, TB-HIV Unit, Antwerp, Belgium.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement